Trusted Resource for Clinical Trials, Protocols & Progress
The document collection process is essential for establishing regulatory and ethical oversight, verifying site qualifications, and maintaining a traceable and compliant trial record. Each document has a role in supporting clinical integrity, subject protection, and audit readiness.
Click to read the full article.
Regulatory submissions are formal communications to competent authorities and ethics committees seeking permission to conduct a clinical trial. These include applications, notifications, and approvals for drugs, devices, or biologics.
Click to read the full article.
Several factors influence the variability in start-up timelines worldwide:
Click to read the full article.
Effective contract and budget management:
Click to read the full article.
Site feasibility is the preliminary assessment of a site’s capability and willingness to conduct a specific clinical trial. It focuses on technical, operational, and regulatory capacity as well as historical performance data.
Click to read the full article.
Start-up delays affect site activation, patient enrollment, and sponsor timelines. They can also compromise compliance with USFDA, EMA, and other regulatory bodies. Proactive identification of these challenges is crucial to prevent project slippage and ensure readiness for inspection.
Click to read the full article.
The Project Manager ensures coordination across departments, vendors, and trial sites. They act as the central communication hub and problem solver during the high-pressure launch period.
Click to read the full article.
Performance tracking offers benefits across all stakeholders:
Click to read the full article.
Traditional manual processes often lead to bottlenecks, delays, and compliance risks. Technology enables:
Click to read the full article.
